Week In Review: China Life Science Companies Raise Nearly $1 Billion Led By Legend's $424 Million US IPO
June 06, 2020 at 14:44 PM EDT
In a successful debut offering, Nanjing Legend Biotech priced its US IPO above the expected range at $23 per ADS, raising $424 million. The company's ADS's climbed 60% higher to $36.60, giving Legend a market capitalization of nearly $5 billion.